Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Binds to the Cell Surface and Translocates to the Nucleus of Human MCF-7 Breast Carcinoma Cells
- 13 April 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 257 (2) , 494-499
- https://doi.org/10.1006/bbrc.1999.0408
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancerInternational Journal of Cancer, 1999
- Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1show vascular endothelial growth factor expressionInternational Journal of Cancer, 1998
- Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) May Be an Autocrine Growth Factor in Scleroderma Fibroblasts.Journal of Investigative Dermatology, 1997
- Optimized Codon Usage and Chromophore Mutations Provide Enhanced Sensitivity with the Green Fluorescent ProteinNucleic Acids Research, 1996
- Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancerInternational Journal of Cancer, 1996
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Growth Stimulation of Human Keratinocytes by Tissue Inhibitor of MetalloproteinasesJournal of Investigative Dermatology, 1991
- Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomasBlood, 1991
- K562 cells produce and respond to human erythroid-potentiating activityBlood, 1988
- Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562Blood, 1988